These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3705002)

  • 21. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing a point-of-care program for coagulation testing.
    Macik BG
    Arch Pathol Lab Med; 1995 Oct; 119(10):929-38. PubMed ID: 7487394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin and partial thromboplastin time: an international survey.
    Poller L; Thomson JM; Yee KF
    Br J Haematol; 1980 Jan; 44(1):161-5. PubMed ID: 7378288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THE PTT TEST: PARTIAL THROMBOPLASTIN TIME. II. ITS USEFULNESS IN THE LABORATORY CONTROL OF PLASMA THERAPY IN HEMOPHILIA.
    MITRAKUL C; DJERASSI I; WOLMAN IJ
    Clin Pediatr (Phila); 1963 Aug; 2():420-4. PubMed ID: 14049448
    [No Abstract]   [Full Text] [Related]  

  • 26. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
    Badylak SF; Van Vleet JF
    Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE PTT TEST: PARTIAL THROMBOPLASTIN TIME. I. ITS VALUE IN THE RECOGNITION OF COAGULATION DISORDERS IN CHILDHOOD.
    MITRAKUL C; WOLMAN IJ; BHANCHET P; DJERASSI I
    Clin Pediatr (Phila); 1963 Aug; 2():415-9. PubMed ID: 14049447
    [No Abstract]   [Full Text] [Related]  

  • 28. The diagnosis of mild haemophilia by the partial thromboplastin time test. WFH/ICTH study of the Manchester method.
    O'Brien PF; North WR; Ingram GI
    Thromb Haemost; 1981 Apr; 45(2):162-8. PubMed ID: 6789495
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experiences with the use of a lyophilized reference plasma for calibrating the determination of thromboplastin time values].
    Flach W; Lutze G; Fritzsche L; Baborowski H
    Z Med Lab Diagn; 1989; 30(4):239-43. PubMed ID: 2773546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of Tityus discrepans scorpion venom on global coagulation test. Preliminary studies].
    Brazón J; Guerrero B; Arocha-Piñango CL; Sevcik C; D'Suze G
    Invest Clin; 2008 Mar; 49(1):49-58. PubMed ID: 18524331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood coagulation physiologic study in tonsillectomy].
    Schwerdtfeger P; Dennebaum R
    HNO; 1984 Nov; 32(11):450-3. PubMed ID: 6511499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated partial thromboplastin time for automated techniques: a comparison of two commonly used reagents.
    Craig S; Stevenson KJ; Taberner DA
    Br J Biomed Sci; 1994 Dec; 51(4):321-7. PubMed ID: 7756937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.
    Douglas AD; Jefferis J; Sharma R; Parker R; Handa A; Chantler J
    Angiology; 2009; 60(3):358-61. PubMed ID: 19398428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of activated recalcification time in thrombocyte-poor plasma].
    Kuhfahl E
    Z Med Lab Diagn; 1986; 27(8):451-7. PubMed ID: 3564626
    [No Abstract]   [Full Text] [Related]  

  • 35. External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome.
    Spannagl M; Dick A; Reinauer H
    Semin Thromb Hemost; 2007 Apr; 33(3):259-64. PubMed ID: 17427060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
    Korsan-Bengtsen K
    Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
    [No Abstract]   [Full Text] [Related]  

  • 37. [Partial thromboplastin time (PTT). I. Its usefulness of preoperative screening in gynecology].
    Cattaneo A; Ottaviano M; Cutrera A
    Riv Ostet Ginecol; 1969 Jan; 24(1):26-37. PubMed ID: 5404736
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid class composition and heparin sensitivity in the activated partial thromboplastin time.
    Stevenson KJ; Easton AC; Thomson JM; Poller L
    Thromb Haemost; 1983 Aug; 50(2):601-3. PubMed ID: 6636037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quality control in the coagulation laboratory with special reference to conventional methods for control of oral anticoagulant therapy].
    Paar D
    Med Lab (Stuttg); 1981; 34(3):83-7. PubMed ID: 7231352
    [No Abstract]   [Full Text] [Related]  

  • 40. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.